133 related articles for article (PubMed ID: 18321815)
1. Uveal vs. cutaneous melanoma. Origins and causes of the differences.
Belmar-Lopez C; Mancheno-Corvo P; Saornil MA; Baril P; Vassaux G; Quintanilla M; Martin-Duque P
Clin Transl Oncol; 2008 Mar; 10(3):137-42. PubMed ID: 18321815
[TBL] [Abstract][Full Text] [Related]
2. The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas.
Makohon-Moore AP; Lipson EJ; Hooper JE; Zucker A; Hong J; Bielski CM; Hayashi A; Tokheim C; Baez P; Kappagantula R; Kohutek Z; Makarov V; Riaz N; Postow MA; Chapman PB; Karchin R; Socci ND; Solit DB; Chan TA; Taylor BS; Topalian SL; Iacobuzio-Donahue CA
Clin Cancer Res; 2021 Mar; 27(5):1516-1525. PubMed ID: 33323400
[TBL] [Abstract][Full Text] [Related]
3. Uveal melanoma: the inflammatory microenvironment.
Bronkhorst IH; Jager MJ
J Innate Immun; 2012; 4(5-6):454-62. PubMed ID: 22302072
[TBL] [Abstract][Full Text] [Related]
4. Identifying biomarkers and novel therapeutic targets in uveal melanoma.
Wessely A; Koch EAT; Vera J; Berking C; Heppt MV
J Dtsch Dermatol Ges; 2024 Jan; 22(1):29-32. PubMed ID: 37902386
[TBL] [Abstract][Full Text] [Related]
5. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.
Whiteman DC; Pavan WJ; Bastian BC
Pigment Cell Melanoma Res; 2011 Oct; 24(5):879-97. PubMed ID: 21707960
[TBL] [Abstract][Full Text] [Related]
6. Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types.
van der Kooij MK; Speetjens FM; van der Burg SH; Kapiteijn E
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31248118
[TBL] [Abstract][Full Text] [Related]
7. Anthropometry in the immunotherapy of cutaneous and ocular melanomas.
Săftescu S; Munteanu M; Popovici D; Dragomir R; Dărăbuș MD; Negru AG; Negru ȘM
Rom J Ophthalmol; 2020; 64(2):190-194. PubMed ID: 32685786
[TBL] [Abstract][Full Text] [Related]
8. Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances.
Strashilov S; Yordanov A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203771
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-dependent drivers of melanoma progression.
D'Aguanno S; Mallone F; Marenco M; Del Bufalo D; Moramarco A
J Exp Clin Cancer Res; 2021 May; 40(1):159. PubMed ID: 33964953
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous adverse effects induced by tebentafusp in patients with metastatic uveal melanoma: a case series and treatment insights.
Rodriguez I; Norman T; Guenther J; Smart K; Kwong A; Berry J; In GK; Worswick S
Clin Exp Dermatol; 2024 Mar; 49(4):392-394. PubMed ID: 37956104
[No Abstract] [Full Text] [Related]
11. FDA Approves Tebentafusp-Tebn For Unresectable Or Metastatic Uveal Melanoma.
Abbas Z; Wally HT; Qureshi FA
J Pak Med Assoc; 2023 Oct; 73(10):2127. PubMed ID: 37876091
[No Abstract] [Full Text] [Related]
12. LXS196 for Metastatic Uveal Melanoma - finally some progress.
Rodrigues A; Cosman R; Joshua AM
Br J Cancer; 2023 May; 128(10):1791-1793. PubMed ID: 36859685
[TBL] [Abstract][Full Text] [Related]
13. Review and comparison of body sites among patients with cutaneous malignant melanoma: an observational study.
Wolinska A; Bowe S; Murray G; Collins S; Feighery C; Roche M; Murad A
Ir J Med Sci; 2023 Aug; 192(4):1629-1630. PubMed ID: 36729224
[No Abstract] [Full Text] [Related]
14. A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.
Harbour JW; Chao DL
Ophthalmology; 2014 Jun; 121(6):1281-8. PubMed ID: 24480708
[TBL] [Abstract][Full Text] [Related]
15. Frequent mutation of BAP1 in metastasizing uveal melanomas.
Harbour JW; Onken MD; Roberson ED; Duan S; Cao L; Worley LA; Council ML; Matatall KA; Helms C; Bowcock AM
Science; 2010 Dec; 330(6009):1410-3. PubMed ID: 21051595
[TBL] [Abstract][Full Text] [Related]
16. Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study.
Herwig-Carl MC; Sharma A; Tischler V; Pelusi N; Loeffler KU; Holz FG; Zeschnigk M; Landreville S; Auw-Haedrich C; Noberini R; Bonaldi T
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):27. PubMed ID: 38349785
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor NFIC functions as a tumor suppressor in lung squamous cell carcinoma progression by modulating lncRNA CASC2.
Zhang H; Luo Z; Tang J; Tian J; Xiao Y; Sun C; Wang T
Cell Cycle; 2022 Jan; 21(1):63-73. PubMed ID: 34985387
[TBL] [Abstract][Full Text] [Related]
18. Uveal Melanoma Metastasis.
Rossi E; Croce M; Reggiani F; Schinzari G; Ambrosio M; Gangemi R; Tortora G; Pfeffer U; Amaro A
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830841
[TBL] [Abstract][Full Text] [Related]
19. A multi-omics study on cutaneous and uveal melanoma.
Zhang Q; Lin ZN; Chen J; Zheng WX
Int J Ophthalmol; 2021; 14(1):32-41. PubMed ID: 33469481
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
